Small-molecule targeting of brachyury transcription factor addiction in chordoma.


Journal

Nature medicine
ISSN: 1546-170X
Titre abrégé: Nat Med
Pays: United States
ID NLM: 9502015

Informations de publication

Date de publication:
02 2019
Historique:
received: 22 01 2018
accepted: 26 11 2018
pubmed: 22 1 2019
medline: 11 5 2019
entrez: 22 1 2019
Statut: ppublish

Résumé

Chordoma is a primary bone cancer with no approved therapy

Identifiants

pubmed: 30664779
doi: 10.1038/s41591-018-0312-3
pii: 10.1038/s41591-018-0312-3
pmc: PMC6633917
mid: NIHMS1514494
doi:

Substances chimiques

Fetal Proteins 0
Protein Kinase Inhibitors 0
Small Molecule Libraries 0
T-Box Domain Proteins 0
Transcription Factors 0
Cyclin-Dependent Kinases EC 2.7.11.22
Brachyury protein EQ43SC3GDB

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

292-300

Subventions

Organisme : NCI NIH HHS
ID : R01 CA215452
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA176152
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA176058
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008307
Pays : United States
Organisme : NCI NIH HHS
ID : U01 CA217848
Pays : United States
Organisme : NCI NIH HHS
ID : R00 CA190861
Pays : United States

Références

Cancer Causes Control. 2001 Jan;12(1):1-11
pubmed: 11227920
Nat Genet. 2003 Jul;34(3):267-73
pubmed: 12808457
Dev Dyn. 2004 Jan;229(1):201-18
pubmed: 14699590
Proc Natl Acad Sci U S A. 2005 Oct 25;102(43):15545-50
pubmed: 16199517
J Pathol. 2006 Jun;209(2):157-65
pubmed: 16538613
Biostatistics. 2007 Jan;8(1):118-27
pubmed: 16632515
Dev Biol. 2006 Jul 1;295(1):128-40
pubmed: 16678811
Nat Rev Cancer. 2006 Aug;6(8):593-602
pubmed: 16862190
Clin Cancer Res. 2007 Apr 15;13(8):2471-8
pubmed: 17438107
Cancer Immunol Immunother. 2009 Mar;58(3):339-49
pubmed: 18641983
Curr Opin Chem Biol. 2008 Aug;12(4):464-71
pubmed: 18706517
Genome Biol. 2008;9(9):R137
pubmed: 18798982
Bioinformatics. 2009 Jul 15;25(14):1754-60
pubmed: 19451168
Nat Genet. 2009 Nov;41(11):1176-8
pubmed: 19801981
Bioinformatics. 2010 Mar 15;26(6):841-2
pubmed: 20110278
Mol Cell. 2010 May 28;38(4):576-89
pubmed: 20513432
Genome Res. 2010 Sep;20(9):1297-303
pubmed: 20644199
Neurosurgery. 2011 Jan;68(1):231-40; discussion 240-1
pubmed: 21099719
Nature. 2010 Dec 16;468(7326):968-72
pubmed: 21107320
J Pathol. 2011 Feb;223(3):327-35
pubmed: 21171078
J Pathol. 2011 Feb;223(3):336-46
pubmed: 21171079
J Neurosurg. 2011 Oct;115(4):760-9
pubmed: 21699479
Nat Methods. 2012 Mar 04;9(4):357-9
pubmed: 22388286
Nature. 2012 Mar 28;483(7391):603-7
pubmed: 22460905
J Orthop Res. 2012 Oct;30(10):1666-73
pubmed: 22504929
J Pathol. 2012 Nov;228(3):274-85
pubmed: 22847733
Nat Genet. 2012 Nov;44(11):1185-7
pubmed: 23064415
Bioinformatics. 2013 Jan 1;29(1):15-21
pubmed: 23104886
Cell. 2013 Apr 11;153(2):320-34
pubmed: 23582323
Nat Methods. 2013 Dec;10(12):1213-8
pubmed: 24097267
Cell. 2013 Nov 7;155(4):934-47
pubmed: 24119843
Science. 2014 Jan 3;343(6166):84-87
pubmed: 24336571
J Biomol Screen. 2014 Jun;19(5):771-81
pubmed: 24464433
Naunyn Schmiedebergs Arch Pharmacol. 2014 Jun;387(6):505-21
pubmed: 24643470
PLoS One. 2014 Jul 01;9(7):e101283
pubmed: 24983247
Nature. 2014 Jul 31;511(7511):616-20
pubmed: 25043025
Nat Biotechnol. 2014 Dec;32(12):1262-7
pubmed: 25184501
Mol Cell. 2014 Oct 23;56(2):219-231
pubmed: 25263595
Curr Protoc Bioinformatics. 2013;43:11.10.1-33
pubmed: 25431634
Genome Biol. 2014;15(12):550
pubmed: 25516281
Lancet Oncol. 2015 Feb;16(2):e71-83
pubmed: 25638683
Sci Data. 2014 Sep 30;1:140035
pubmed: 25984343
Mol Cell. 2015 Oct 15;60(2):328-37
pubmed: 26439301
Cancer Discov. 2015 Nov;5(11):1210-23
pubmed: 26482930
Nat Chem Biol. 2015 Dec;11(12):973-980
pubmed: 26502155
Nature. 2016 Feb 4;530(7588):57-62
pubmed: 26814967
J Pathol. 2016 Jul;239(3):320-34
pubmed: 27102572
Cancer Discov. 2016 Aug;6(8):914-29
pubmed: 27260156
Nat Chem Biol. 2016 Oct;12(10):876-84
pubmed: 27571479
Pharmacol Ther. 2017 May;173:83-105
pubmed: 28174091
Cell. 2017 Feb 9;168(4):629-643
pubmed: 28187285
Proc Natl Acad Sci U S A. 1988 Mar;85(5):1417-21
pubmed: 2830618
Clin Cancer Res. 2017 Jul 1;23(13):3251-3262
pubmed: 28351928
Sci Rep. 2017 May 17;7(1):2032
pubmed: 28515451
Nat Chem Biol. 2017 Oct;13(10):1102-1108
pubmed: 28805801
Cell Chem Biol. 2017 Sep 21;24(9):1075-1091
pubmed: 28938087
Cell Rep. 2017 Oct 10;21(2):495-507
pubmed: 29020634
Nat Commun. 2017 Oct 12;8(1):890
pubmed: 29026114
Nat Genet. 2017 Dec;49(12):1779-1784
pubmed: 29083409
J Pathol. 1993 Dec;171(4):253-5
pubmed: 8158454

Auteurs

Tanaz Sharifnia (T)

Broad Institute of Harvard and MIT, Cambridge, MA, USA. tanaz@broadinstitute.org.

Mathias J Wawer (MJ)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Ting Chen (T)

New York University Langone Medical Center, New York, NY, USA.

Qing-Yuan Huang (QY)

New York University Langone Medical Center, New York, NY, USA.
Shanghai General Hospital, Shanghai Jiao Tong University, Shanghai, China.

Barbara A Weir (BA)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Janssen R&D, Cambridge, MA, USA.

Ann Sizemore (A)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
University of Pennsylvania, Philadelphia, PA, USA.

Matthew A Lawlor (MA)

Dana-Farber Cancer Institute, Boston, MA, USA.
Massachusetts General Hospital, Charlestown, MA, USA.

Amy Goodale (A)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Glenn S Cowley (GS)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Janssen R&D, Spring House, PA, USA.

Francisca Vazquez (F)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Christopher J Ott (CJ)

Dana-Farber Cancer Institute, Boston, MA, USA.
Massachusetts General Hospital, Charlestown, MA, USA.

Joshua M Francis (JM)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Gritstone Oncology, Cambridge, MA, USA.

Slim Sassi (S)

Massachusetts General Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Patricia Cogswell (P)

Chordoma Foundation, Durham, NC, USA.

Hadley E Sheppard (HE)

Baylor College of Medicine, Houston, TX, USA.

Tinghu Zhang (T)

Dana-Farber Cancer Institute, Boston, MA, USA.

Nathanael S Gray (NS)

Dana-Farber Cancer Institute, Boston, MA, USA.

Paul A Clarke (PA)

Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK.

Julian Blagg (J)

Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK.

Paul Workman (P)

Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, London, UK.

Josh Sommer (J)

Chordoma Foundation, Durham, NC, USA.

Francis Hornicek (F)

Massachusetts General Hospital, Boston, MA, USA.
UCLA Medical Center, Santa Monica, CA, USA.

David E Root (DE)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.

William C Hahn (WC)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.
Dana-Farber Cancer Institute, Boston, MA, USA.

James E Bradner (JE)

Dana-Farber Cancer Institute, Boston, MA, USA.
Novartis Institutes for BioMedical Research, Cambridge, MA, USA.

Kwok K Wong (KK)

New York University Langone Medical Center, New York, NY, USA.

Paul A Clemons (PA)

Broad Institute of Harvard and MIT, Cambridge, MA, USA.

Charles Y Lin (CY)

Baylor College of Medicine, Houston, TX, USA. Charles.Y.Lin@bcm.edu.

Joanne D Kotz (JD)

Broad Institute of Harvard and MIT, Cambridge, MA, USA. jkotz@jnanatx.com.
Jnana Therapeutics, Boston, MA, USA. jkotz@jnanatx.com.

Stuart L Schreiber (SL)

Broad Institute of Harvard and MIT, Cambridge, MA, USA. stuart_schreiber@harvard.edu.
Harvard University, Cambridge, MA, USA. stuart_schreiber@harvard.edu.
Howard Hughes Medical Institute, Chevy Chase, MD, USA. stuart_schreiber@harvard.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH